Buxton M - Search Results

1

Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.

Sullivan SD, Buxton M, Andersson LF, Lamm CJ, Liljas B, Chen YZ, Pauwels RA, Weiss KB. Sullivan SD, et al. Among authors: buxton m. J Allergy Clin Immunol. 2003 Dec;112(6):1229-36. doi: 10.1016/j.jaci.2003.09.025. J Allergy Clin Immunol. 2003. PMID: 14657888 Clinical Trial.

2

Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.

Weiss K, Buxton M, Andersson FL, Lamm CJ, Liljas B, Sullivan SD. Weiss K, et al. Among authors: buxton m. Pediatr Allergy Immunol. 2006 May;17 Suppl 17:21-7. doi: 10.1111/j.1600-5562.2006.00381.x. Pediatr Allergy Immunol. 2006. PMID: 16573705 Clinical Trial.

3

Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S. Ramsey S, et al. Among authors: buxton m. Value Health. 2005 Sep-Oct;8(5):521-33. doi: 10.1111/j.1524-4733.2005.00045.x. Value Health. 2005. PMID: 16176491 Free article. Review.

4

Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT investigators. Lindgren P, et al. Among authors: buxton m. Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):29-36. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 15703503 Clinical Trial.

5

Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial.

Kendrick T, Peveler R, Longworth L, Baldwin D, Moore M, Chatwin J, Thornett A, Goddard J, Campbell M, Smith H, Buxton M, Thompson C. Kendrick T, et al. Among authors: buxton m. Br J Psychiatry. 2006 Apr;188:337-45. doi: 10.1192/bjp.188.4.337. Br J Psychiatry. 2006. PMID: 16582060 Clinical Trial.

6

Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria.

Coyle D, Buxton MJ, O'Brien BJ. Coyle D, et al. Health Econ. 2003 May;12(5):421-7. doi: 10.1002/hec.788. Health Econ. 2003. PMID: 12720259

7

Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion.

Claxton K, Sculpher M, Culyer A, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J. Claxton K, et al. Among authors: buxton m. Health Econ. 2006 Jan;15(1):1-4. doi: 10.1002/hec.1081. Health Econ. 2006. PMID: 16365910

8

Unfinished symphony: a tribute to the life and career of Bernie O'Brien (1959-2004).

Briggs A, Buxton M, Drummond M, Goeree R, Sculpher MJ, Willan AR. Briggs A, et al. Among authors: buxton m. Med Decis Making. 2004 Sep-Oct;24(5):538-44. doi: 10.1177/0272989X04269200. Med Decis Making. 2004. PMID: 15359004

9

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J, O'Hagan T. Claxton K, et al. Among authors: buxton m. Health Econ. 2005 Apr;14(4):339-47. doi: 10.1002/hec.985. Health Econ. 2005. PMID: 15736142 Free article.

10

The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm.

Campbell H, Briggs A, Buxton M, Kim L, Thompson S. Campbell H, et al. Among authors: buxton m. J Health Serv Res Policy. 2007 Jan;12(1):11-7. doi: 10.1258/135581907779497594. J Health Serv Res Policy. 2007. PMID: 17244392 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters